Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
14.86
+0.12 (0.81%)
Sep 30, 2026, 4:08 PM HKT

Sinopharm Group Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
571,924575,168584,508596,570552,148521,051
Revenue Growth
-0.68%-1.60%-2.02%8.04%5.97%14.16%
Gross Profit
40,39741,67244,25548,51247,43444,051
Operating Income
16,85517,23017,81922,31822,76420,984
Net Income
7,0937,1557,0509,0548,5267,759
Earnings Per Share
2.272.292.262.902.742.49
EPS Growth
4.00%1.37%-22.10%6.02%10.02%7.63%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Eliminations
-24,696-22,997-22,860-20,769-18,496-15,913
Medical Device Distribution
115,339115,538117,915130,213120,851108,129
Other Business
9,0658,8539,10610,38610,2099,821
Retail Pharmacy
39,85638,38335,98135,68932,97929,059
Pharmaceutical Distribution
432,360435,392444,365441,051406,604389,955
Total
571,924575,168584,508596,570552,148521,051

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31,04551,55457,48667,13958,42146,353
Total Debt
81,31670,96076,38673,78269,59068,368
Net Cash (Debt)
-50,271-19,407-18,900-6,643-11,169-22,016
Net Cash Growth
------
Net Cash Per Share
-16.11-6.22-6.06-2.13-3.58-7.05

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
24,48714,13811,54617,17320,9649,308
Capital Expenditures
-1,455-1,496-1,471-1,960-2,127-2,074
Free Cash Flow
23,03112,64210,07515,21318,8377,234
Free Cash Flow Growth
32.72%25.49%-33.78%-19.23%160.38%-21.85%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
7.06%7.25%7.57%8.13%8.59%8.45%
Operating Margin
2.95%3.00%3.05%3.74%4.12%4.03%
Pretax Margin
2.54%2.57%2.40%3.27%3.36%3.26%
Profit Margin
1.24%1.24%1.21%1.52%1.54%1.49%
FCF Margin
4.03%2.20%1.72%2.55%3.41%1.39%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.8050.6900.6800.8700.8200.750
Dividend Per Share Growth
6.90%1.47%-21.84%6.10%9.33%8.70%
Dividend Yield
5.42%4.15%3.71%5.36%5.53%6.73%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.677.628.866.406.425.56
Forward PE
5.176.857.015.826.054.93
P/FCF Ratio
1.744.316.203.812.915.96
PS Ratio
0.070.100.110.100.100.08